The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

This approval strengthens Zydus’ position in the US pharmaceutical market, bringing the company’s total to 419 approvals. Since beginning its filing process in the 2003-04 fiscal year ...

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist ...

Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the USFDA. Sun Pharma is recalling Morphine Sulfate tablets for failed ...

The product is the generic equivalent of Nizoral Shampoo, 2 per cent. The approval adds to Zydus’s growing pharmaceutical portfolio in the US market, where Ketoconazole shampoo generated annual ...

Zydus Lifesciences has entered exclusive negotiations ... The company will leverage its global presence in pharmaceuticals to launch its medtech play. “Because of our global footprint in ...

Zydus Lifesciences share price today, March 13: The share price of Zydus Lifesciences has cracked 2.6% in the last five days. (Image: Freepik) Nuvama Institutional Equities slashed the target ...

Zydus Lifesciences is attempting to move up the value chain in the global pharma industry with its expanding focus on the medical technology segment. As part of the above strategy, Zydus ...

Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...

Zydus Lifesciences, one of India's leading ... But analysts caution that replicating the success companies had with pharmaceuticals, especially generic medicines, in the MedTech space won't ...